Surgeons develop 2 ways to ‘restart’ hearts without a donor’s body

The Challenge of Heart Transplantation and Donor Shortage

Heart transplants are critical for patients with severe cardiac failure, yet the availability of donor hearts remains a major bottleneck. Traditionally, donor hearts come from individuals declared brain dead but whose hearts continue to beat, ensuring the organ's viability. However, the number of such donors falls short of the growing demand, particularly in pediatric cases.

In the United States alone, approximately 500 children die each year waiting for a heart transplant. Expanding the donor pool to include hearts from donors declared dead by circulatory criteria (DCD) could significantly alleviate this shortage. Yet, using DCD hearts introduces complex medical and ethical challenges, particularly concerning the definition of death and the process of reanimating the heart.

Ethical Concerns Around Reanimating Hearts In Situ

One experimental approach, normothermic regional perfusion (NRP), involves restoring oxygenated blood flow to a donor’s heart while it remains in the deceased body. This technique has shown promise in reanimating hearts after circulatory death, allowing them to be transplanted successfully.

However, NRP has raised ethical debates. Critics argue that reestablishing circulation in a deceased individual blurs the line between life and death, potentially conflicting with legal and moral definitions. Some medical institutions have banned the practice, and professional bodies like the American College of Physicians have expressed concern, describing the procedure as ethically problematic.

These controversies have motivated researchers to develop alternative methods that avoid reanimating the heart within the donor’s body.

Technique One: Ex Vivo Heart Reanimation on the Surgical Table

Surgeons at Duke University pioneered a procedure that removes the donor heart and reanimates it outside the body. In a groundbreaking case, they extracted the heart of a one-month-old infant donor and connected it to a system that pumps oxygenated blood through the organ.

During this process, the heart begins to beat again on the surgical table, effectively 'waking up' in a controlled environment. The procedure takes less than six minutes, after which the heart is cooled and transported to the recipient hospital for transplantation.

This technique was successfully applied to a three-month-old recipient, who received the reanimated heart and was discharged two months later with no signs of rejection or failure. This milestone demonstrates the potential for safely expanding the donor pool to include hearts previously considered unusable.

Technique Two: Cold Preservation with Oxygenated Fluid Infusion

A second approach developed by Vanderbilt University Medical Center involves preserving DCD hearts through cold perfusion. Immediately after donor death, surgeons flush the heart’s aorta with a chilled solution containing oxygenated red blood cells, electrolytes, vitamins, and preservatives.

This cold, nutrient-rich fluid keeps the heart in a relaxed, preserved state, protecting it from damage during transport. Unlike the first method, this technique does not require the heart to be restarted before transplantation; instead, the heart is transplanted while still in a preserved state and 'resuscitated' after implantation.

This method helps circumvent the ethical issues associated with reanimating the heart in the donor’s body and offers a practical way to extend the viability of hearts from DCD donors.

Potential Impact on Pediatric Heart Transplantation

The combined use of these two techniques could significantly increase the number of hearts available for transplantation, particularly benefiting pediatric patients. Researchers estimate that these methods could add approximately 100 additional pediatric heart transplants annually in the United States alone.

Given the current annual pediatric mortality rate of around 500 children awaiting heart transplants, this increase represents a meaningful improvement in survival chances. Moreover, the new procedures may reduce costs and logistical challenges associated with organ preservation and transport.

While still in early stages, these innovations hold promise for wider adoption and refinement, potentially transforming heart transplantation practices and saving many lives.

Balancing Innovation with Ethical Responsibility

These advancements highlight the delicate balance between medical innovation and ethical responsibility. By developing techniques that avoid reanimating hearts within deceased donors, surgeons address concerns about the definition of death and respect for donor bodies.

Ongoing dialogue among clinicians, ethicists, policymakers, and the public will be essential to guide the adoption of these methods. Transparent communication about the procedures, their benefits, and ethical considerations will help build trust and acceptance.

As the medical community continues to refine these approaches, they may pave the way for broader acceptance of DCD heart transplantation, ultimately improving patient outcomes while upholding ethical standards.

What this means

The development of these two innovative heart preservation and reanimation techniques marks a significant advancement in cardiac transplantation. By expanding the donor pool and addressing ethical complexities, they offer new hope for patients, especially children, awaiting life-saving heart transplants. While further research and ethical deliberation are necessary, these methods have the potential to transform transplant medicine, reduce waiting list mortality, and improve outcomes for countless patients worldwide.